The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Cryptogenic fibrosing alveolitis and lung cancer.
Open accessAbstract
Lung cancer was found in 20 (9.8%) of 205 patients with cryptogenic fibrosing alveolitis (CFA) or 12.9% of the 155 patients in this series followed to death. An excess relative risk of lung cancer of 14.1 was found in patients with CFA compared to the general population of comparable age and sex, allowing for the lengths of follow-up of the CFA patients. The relative risk for male smokers was (observed/expected) 15+1.06 = 14.2, and for female smokers (O/E) 2/0.3 = 6.7. Only one male and one female non-smoker had lung cancer. These data suggest that there is an excess risk of lung cancer not wholly accounted for by age, sex, or smoking habit. The distribution of histological types was not obviously different from that found in lung cancer without pulmonary fibrosis. Large opacities suggestive of lung cancer were present at the time of first hospital attendance for symptoms relating to CFA in four of the 20 patients. Finger clubbing was present in 19 (95%) compared with 116/185 (63%) of those so far not developing cancer. There were no other clinical differences at presentation. In particular, cancer was not found especially in those with longer survival from the onset of symptoms of CFA or with a greater initial radiographic change.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asbestos Exposure and Neoplasia
Selikoff, I. J., Churg, J., & Hammond, E. C. (1964) · JAMA · doi:10.1001/jama.1964.03060270028006 · Cited by 664
Circulating Immune Complexes in the Idiopathic Interstitial Pneumonias
Dreisin, R. B., Schwarz, M. I., Theofilopoulos, A. N., & Stanford, R. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980701 · Cited by 278
The prognosis of cryptogenic fibrosing alveolitis
Stack, B. H. R., Choo-Kang, Y. F. J., & Heard, B. E. (1972) · Thorax · doi:10.1136/thx.27.5.535 · Cited by 240
MANAGEMENT EFFICIENCY IN THE HEALTH SERVICE
SEALE, J. (1961) · The Lancet · doi:10.1016/s0140-6736(61)90714-0 · Cited by 199
COMBINED EFFECT OF ASBESTOS EXPOSURE AND SMOKING ON MORTALITY FROM LUNG CANCER IN FACTORY WORKERS
Berry, G., Newhouse, M. L., & Turok, M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91867-3 · Cited by 138
Antibodies in some chronic fibrosing lung diseases
Warwick, M. T., & HASLAM, P. L. (1971) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1971.tb02450.x · Cited by 80
Alveolar cell carcinoma occurring in idiopathic interstitial pulmonary fibrosis
Jones, A. W. (1970) · British Journal of Diseases of the Chest · doi:10.1016/s0007-0971(70)80032-8 · Cited by 27
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Mechanisms in the Pathogenesis of Asbestosis and Silicosis
MOSSMAN, B. T., & CHURG, A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9707141 · Cited by 971
Lung cancer in never smokers – A review
Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 960
Interstitial lung disease guideline
Wells, A. U., Hirani, N., & on behalf of the BTS Interstitial Lung Disease Guideline Group, A. S. O. T. B. T. S. S. O. C. C. (2008) · Thorax · doi:10.1136/thx.2008.101691 · Cited by 866
Lung Cancer in Never Smokers: A Review
Subramanian, J., & Govindan, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8015 · Cited by 655
Metadata
- Authors
- Turner-Warwick, M., Lebowitz, M., Burrows, B., & Johnson, A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 1980-07-01
- Volume
- 35
- Issue
- 7
- Pages
- 496-499
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2096554743
- Cited by
- 349
- References
- 7
- FWCI
- 6.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.